| Multiple Sclerosis |
1 |
1 |
| Biomarker |
0 |
0.88 |
| Brain |
0 |
0.24 |
| Multiple Sclerosis Prognosis |
0 |
0.23 |
| Disability |
0 |
0.16 |
| Prognosis |
0 |
0.16 |
| Revenue and Practice Management |
0 |
0.11 |
| Blood |
0 |
0.08 |
| Body Mass Index |
0 |
0.08 |
| Canada |
0 |
0.08 |
| Clinical Guidelines |
0 |
0.08 |
| Disease-Modifying Therapy |
0 |
0.08 |
| Fellowship |
0 |
0.08 |
| Grant |
0 |
0.08 |
| Hospital |
0 |
0.08 |
| Multiple Sclerosis Relapse |
0 |
0.08 |
| Multiple Sclerosis Risk |
0 |
0.08 |
| Multiple Sclerosis Treatment |
0 |
0.08 |
| Pedal |
0 |
0.08 |
| Salary and Compensation |
0 |
0.08 |
| Scan |
0 |
0.08 |
| Secondary Progressive Multiple Sclerosis |
0 |
0.08 |
| Treatment Guidelines |
0 |
0.06 |